TGF-β3-induced palatogenesis requires matrix metalloproteinases

被引:134
作者
Blavier, L
Lazaryev, A
Groffen, J
Heisterkamp, N
DeClerck, YA [1 ]
Kaartinen, V
机构
[1] Childrens Hosp Los Angeles, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA
[3] Childrens Hosp Los Angeles, Dept Pathol, Dev Biol Program, Los Angeles, CA 90027 USA
[4] Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA
关键词
D O I
10.1091/mbc.12.5.1457
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cleft lip and palate syndromes are among the most common congenital malformations in humans. Mammalian palatogenesis is a complex process involving highly regulated interactions between epithelial and mesenchymal cells of the palate to permit correct positioning of the palatal shelves, the remodeling of the extracellular matrix (ECM), and subsequent fusion of the palatal shelves. Here we show that several matrix metalloproteinases (MMPs), including a cell membrane-associated MMP (MT1-MMP) and tissue inhibitor of metalloproteinase-2 (TIMP-2) were highly expressed by the medial edge epithelium (MEE). MMP-13 was expressed both in MEE and in adjacent mesenchyme, whereas gelatinase A (MMP-2) was expressed by mesenchymal cells neighboring the MEE. Transforming growth factor (TGF)-beta3-deficient mice, which suffer from clefting of the secondary palate, showed complete absence of TIMP-2 in the midline and expressed significantly lower levels of MMP-13 and slightly reduced levels of MMP-2. In concordance with these findings, MMP-13 expression was strongly induced by TGF-beta3 in palatal fibroblasts. Finally, palatal shelves from prefusion. wild-type mouse embryos cultured in the presence of a synthetic inhibitor of MMPs or excess of TIMP-2 failed to fuse and MEE cells did not transdifferentiate, phenocopying the defect of the TGF-beta3-deficient mice. Our observations indicate for the first time that the proteolytic degradation of the ECM by MMPs is a necessary step for palatal fusion.
引用
收藏
页码:1457 / 1466
页数:10
相关论文
共 49 条
  • [1] TNF-α converting enzyme (TACE) is inhibited by TIMP-3
    Amour, A
    Slocombe, PM
    Webster, A
    Butler, M
    Knight, CG
    Smith, BJ
    Stephens, PE
    Shelley, C
    Hutton, M
    Knäuper, V
    Docherty, AJP
    Murphy, G
    [J]. FEBS LETTERS, 1998, 435 (01) : 39 - 44
  • [2] Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
    Basbaum, CB
    Werb, Z
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (05) : 731 - 738
  • [3] MATRIX METALLOPROTEINASES - A REVIEW
    BIRKEDALHANSEN, H
    MOORE, WGI
    BODDEN, MK
    WINDSOR, LJ
    BIRKEDALHANSEN, B
    DECARLO, A
    ENGLER, JA
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) : 197 - 250
  • [4] Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development
    Blavier, L
    DeClerck, YA
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (08) : 1513 - 1527
  • [5] BRUNET CL, 1993, INT J DEV BIOL, V37, P451
  • [6] The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A - A kinetic study
    Butler, GS
    Butler, MJ
    Atkinson, SJ
    Will, H
    Tamura, T
    van Westrum, SS
    Crabbe, T
    Clements, J
    d'Ortho, MP
    Murphy, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) : 871 - 880
  • [7] CARETTE MJM, 1992, DEVELOPMENT, V114, P379
  • [8] Murine TIMP-2 gene-targeted mutation
    Caterina, J
    Caterina, N
    Yamada, S
    Holmbäck, K
    Longenecker, G
    Shi, J
    Netzel-Arnett, S
    Engler, J
    Yermovski, A
    Windsor, J
    Birkedal-Hansen, H
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 528 - 530
  • [9] CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377
  • [10] TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP, AKA EPA) - STRUCTURE, CONTROL OF EXPRESSION AND BIOLOGICAL FUNCTIONS
    DENHARDT, DT
    FENG, B
    EDWARDS, DR
    COCUZZI, ET
    MALYANKAR, UM
    [J]. PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) : 329 - 341